Rhizophora racemosa
What's the taxonomical classification of Rhizophora racemosa?
Rhizophora racemosa belongs to the kingdom Plantae and is classified under the phylum Streptophyta. Within this group, it is categorized under the class Equisetopsida and the subclass Magnoliidae. Its taxonomic progression continues through the order Malpighiales and the family Rhizophoraceae, eventually reaching its specific classification within the genus Rhizophora. Finally, it is identified at the species level as Rhizophora racemosa.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Rhizophoraceae |
| Genus | Rhizophora |
| Species | racemosa |
What are the morphological characteristics of this plant?
Rhizophora racemosa has a woody structure characterized by a single trunk, pinnately compound leaves with elliptical leaflets, and distinctive stilt roots that emerge from the lower stem to provide stability in soft mud. The leaves are leathery and evergreen, typically featuring an entire margin and an acute apex. Its small, white flowers are arranged in axillary racemes, which gives the species its specific epithet. The plant develops long, slender viviparous propagules that drop from the tree to colonize new sediment. These specialized root systems allow the plant to thrive in the anaerobic conditions of intertidal mangrove ecosystems.
What is the geographical distribution of this plant?
This plant is native to the tropical and subtropical coastal regions of the Atlantic Ocean, specifically ranging from the coast of Florida through the Caribbean islands and down to Brazil. It primarily inhabits brackish and saline environments such as mangrove swamps, estuaries, and tidal flats. The species is most frequently found in the intertidal zones where it can anchor its roots in soft, muddy sediments. Its distribution is strictly limited to warm climates that lack prolonged freezing temperatures. This specific geographic range makes it a vital component of the coastal ecosystems found throughout the Neotropics.
How is this plant cultivated?
This plant Rhizophora racemosa, commonly known as the red mangrove, is cultivated primarily through the propagation of propagules collected from mature trees in saline coastal environments.
These specialized seedlings are often planted directly into soft, anaerobic mudflats or nurtured in nurseries with brackish water before transplantation. Success depends on maintaining specific tidal inundation patterns and ensuring the substrate has sufficient salinity to support their specialized salt-excreting roots. Monitoring for natural sedimentation and protecting young plants from excessive wave energy are critical steps in establishing a healthy stand.
Proper site selection in tropical or subtropical intertidal zones is essential for the long-term survival of the species.
What parts of this plant are used medicinally?
This plant Rhizophora racemosa is utilized medicinally through its bark and leaves to treat various ailments. The bark is often prepared as a decoction to address issues such as diarrhea or to serve as an astringent for wound healing. Extracts from the leaves are similarly employed in traditional practices to manage inflammation and other physiological concerns. These specific components contain bioactive compounds that contribute to their therapeutic properties. Local communities rely on these different plant parts to maintain diverse health remedies.
According to a study published by "Antioxidants (Basel, Switzerland)", methanolic, ethyl acetate and aqueous leaf and bark extracts of Rhizophora racemosa were prepared using homogenizer-assisted extraction (HAE), infusion and maceration. These extracts were screened for antioxidant capacities including radical scavenging (DPPH, ABTS), reducing potential (CUPRAC, FRAP), total antioxidant capacity and chelating power. The plant was also evaluated for anti-diabetic (alpha-amylase, alpha-glucosidase), anti-tyrosinase and anti-cholinesterase (AChE, BChE) activities. Methanolic leaf and bark extracts prepared by both HAE and maceration were found to abound with phenolics, flavonoids, phenolic acids and flavonols. The highest enzymatic inhibitory activity recorded was with the tyrosinase enzyme. Finally, docking against lanosterol-14alpha-demethylase and E. coli DNA gyrase yielded affinities in the submicromoler-micromolar range.
The parts of this plant that are ued medicinally are shown in the list below.
- bark
- leaf
What traditional systems uses this plant?
This plant, Rhizophora racemosa, has been utilized by various indigenous and coastal communities for centuries as a source of medicinal tannins, construction material, and fuel.
Its bark is traditionally decocted to create astringent washes used for treating skin ailments and soothing gastrointestinal distress. Historically, the dense, rot-resistant wood has been harvested to build durable structures and tools capable of withstanding tropical humidity. In many maritime cultures, the plant also served as a critical component in the production of natural dyes for textiles.
Furthermore, its presence in mangrove ecosystems has long provided essential habitat and food security for local populations relying on coastal resources.
What are the pharmacological activities of Rhizophora racemosa?
This plant has antibacterial, antimycotic, antioxidant, anti-diabetic, and anti-cholinesterase pharmacological activities. The presence of diverse secondary metabolites allows its extracts to inhibit the growth of various pathogenic bacteria and fungi. Its potent antioxidant properties help neutralize free radicals, thereby reducing oxidative stress within biological systems. Additionally, the plant demonstrates potential in managing metabolic disorders through its anti-diabetic mechanisms. Finally, its anti-cholinesterase activity suggests a role in supporting neurological functions by regulating neurotransmitter levels.
According to a study published by "Antioxidants (Basel, Switzerland)", Rhizophora racemosa extracts were evaluated for various pharmacological activities including antioxidant capacities through radical scavenging (DPPH, ABTS), reducing potential (CUPRAC, FRAP), total antioxidant capacity, and chelating power. The plant was also studied for anti-diabetic activities involving alpha-amylase and alpha-glucosidase, as well as anti-tyrosinase and anti-cholinesterase (AChE, BChE) activities. Research showed the highest enzymatic inhibitory activity was recorded with the tyrosinase enzyme. In silico docking studies yielded affinities in the submicromolar-micromolar range to support the observed anti-microbial effects. These extracts may serve as novel sources of phytoanti-oxidants and enzyme inhibitors.
The primary pharmacological activities of this plant are shown in the list below.
- antibacterial
- antimycotic
- antioxidant
- anti-diabetic
- anti-cholinesterase
What medicinal compounds this plant contains?
This plant contains several bioactive medicinal compounds including apiagenin, flavonoids, flavonols, isovitexin, and luteolin. These phytochemicals contribute to the diverse therapeutic potential observed in Rhizophora racemosa extracts. The presence of various flavonoids and flavonols suggests significant antioxidant and anti-inflammatory properties. Specifically, compounds like apiagenin and luteolin are known for their roles in modulating cellular responses. Furthermore, the inclusion of isovitexin adds to the complex chemical profile that supports its traditional medicinal uses.
According to a study published by "Antioxidants (Basel, Switzerland)", methanolic leaf and bark extracts of Rhizophora racemosa prepared by homogenizer-assisted extraction contained phenolics, flavonoids, phenolic acids, and flavonols. The methanolic leaf and bark extracts prepared by HAE exhibited the highest radical scavenging, reducing potential, and total antioxidant capacity. The highest enzymatic inhibitory activity recorded was with the tyrosinase enzyme. Bioinformatics analysis predicted interactions between tyrosinase and multiple secondary metabolites including apigenin, luteolin, vitexin, isovitexin, procyanidin B, quercetin, and methoxy-trihydroxyflavone. These compounds were docked against lanosterol-14α-demethylase and E. coli DNA gyrase, yielding affinities in the submicromolar-micromolar range.
The primary medicinal compounds of this plant are shown in the list below.
- flavonoids
- flavonols
- isovitexin
- phenolic acids
- phenolics
What health conditions is this plant used for?
This plant is used for treating bacterial infections and mycotic infections due to its potent antimicrobial properties. Extracts from the bark and leaves contain bioactive compounds that effectively combat various pathogenic microorganisms. These chemical constituents work by inhibiting the growth of harmful bacteria that cause skin or systemic issues. Additionally, the plant demonstrates significant activity against fungal agents responsible for mycotic infections. This medicinal versatility makes it a valuable resource in traditional pharmacology for managing diverse infectious ailments.
According to a study published by "Antioxidants (Basel, Switzerland)", Rhizophora racemosa was evaluated for several medicinal properties including anti-diabetic activities through α-amylase and α-glucosidase inhibition. The plant was also investigated for anti-tyrosinase and anti-cholinesterase activities, specifically targeting AChE and BChE. Research into its antimicrobial potential examined antimycotic and antibacterial effects against 14 different microorganisms such as Escherichia coli and Staphylococcus aureus. In silico docking studies against lanosterol-14α-demethylase and E. coli DNA gyrase yielded affinities in the submicromolar-micromolar range. Ultimately, the extracts of Rhizophora racemosa serve as sources of phyto-antioxidants and enzyme inhibitors.
The main health conditions this plant is used for are shown in the list below.
- bacterial infections
- mycotic infections
What are the herbal preparations of this plant?
This plant is Rhizophora racemosa, a species of red mangrove used to create medicinal herbal preparations such as aqueous bark extract. This specific liquid preparation is often derived by boiling the bark in water to release its bioactive tannins and polyphenols. These compounds are traditionally utilized in various cultures for their antimicrobial and astringent properties. Researchers frequently study these extracts to evaluate their potential in treating gastrointestinal issues and skin inflammations. The chemical complexity of the bark makes it a significant subject in ethnobotanical studies.
According to a study published by "Antioxidants (Basel, Switzerland)", methanolic, ethyl acetate and aqueous leaf and bark extracts of Rhizophora racemosa were prepared using homogenizer-assisted extraction (HAE), infusion and maceration. The methanolic leaf and bark extracts prepared by both HAE and maceration were found to abound with phenolics, flavonoids, phenolic acids and flavonols. Results showed that the methanolic leaf and bark extracts prepared by HAE exhibited the highest radical scavenging, reducing potential and total antioxidant capacity. The highest enzymatic inhibitory activity recorded for the plant was with the tyrosinase enzyme. In silico docking studies yielded affinities in the submicromolar-micromolar range for compounds such as apigenin, luteolin, vitexin, isovitexin, procyanidin B, quercetin and methoxy-trihydroxyflavone. These extracts of Rhizophora racemosa may be considered novel sources of phytoantioxidants and enzyme inhibitors.
The main herbal preparations of this plant are shown in the list below.
- aqueous bark extract
What side effects this plant can have?
This plant can cause adverse health effects including skin irritation, digestive upset, and potential toxicity if consumed in improper quantities. While some cultures use its extracts for medicinal purposes, the chemical compounds within the bark and leaves can act as irritants to sensitive tissues. Ingesting concentrated forms may lead to nausea, vomiting, or abdominal pain in certain individuals. Furthermore, the high tannin content characteristic of this species can interfere with nutrient absorption if used excessively. Careful monitoring is necessary to avoid unintended physiological reactions when interacting with its derivatives.
The main side effects this plant can have are shown in the list below.
What herbs are paired with Rhizophora racemosa?
This plant, Rhizophora racemosa, is most effectively paired with herbs such as ginger, turmeric, and cinnamon to enhance its therapeutic properties.
These combinations are often utilized in traditional preparations to balance the astringent qualities of the red mangrove bark. Ginger and turmeric specifically work to complement the anti-inflammatory potential found within the plant's extracts. Cinnamon is frequently added to these mixtures to improve the palatability of the bitter decoctions.
Such pairings are studied for their synergistic effects on digestive and immune health.